This systematic review and meta-analysis was conducted to identify a 'normative' sympathetic response to isometric handgrip and post-exercise circulatory occlusion. Structured searches of databases were performed until June 2024. We included all primary studies (other than systematic reviews and meta-analyses), and inclusion criteria were: population (all populations); intervention (isometric handgrip and post-exercise circulatory occlusion); comparator (baseline); and outcome (MSNA). One-hundred fifty-eight studies (n = 3551) were included. Burst frequency was elevated during handgrip (n = 1853; MD, 12.19bursts/min; 95 % CI, 11.09, 13.28; I = 94 %; p < 0.00001) and during PECO (n = 948; MD, 11.42bursts/min; 95 % CI, 10.10, 12.75; I = 65 %; p < 0.00001). A similar pattern was observed for burst incidence in handgrip (n = 1074; MD, 8.50bursts/100 hbs; 95 % CI, 7.07, 9.93; I2 = 39 %; p < 0.00001) and PECO (n = 560; MD, 14.87bursts/100 hbs; 95 % CI, 12.65, 17.10; I2 = 43 %; p < 0.00001). Subgroup analyses indicated a larger response in burst frequency and incidence during handgrip exercise in healthy individuals compared to individuals with cardiovascular diseases or other conditions (p < 0.05). A similar response in burst frequency to PECO was observed with subgroup differences between healthy individuals and individuals with cardiovascular diseases and other conditions (p < 0.00001). MSNA is elevated during handgrip exercise across a range of handgrip protocols, populations, and co-interventions. Increases in MSNA during PECO supports the role of the metaboreflex separate to the exercise pressor reflex. A blunted sympathetic response to handgrip and PECO in individuals with cardiovascular diseases contradicts the current understanding of general sympathetic hyperactivity in these populations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.autneu.2025.103251 | DOI Listing |
Background: People with cystic fibrosis (pwCF) often have multifactorial peripheral muscle abnormalities attributed to, for example, malnutrition, steroid use, altered redox balance and, potentially, CF-specific intrinsic alterations. Malnutrition in CF now includes an increasing prevalence of overweight and obesity, particularly in those receiving CF transmembrane conductance regulator (CFTR) modulator therapy (CFTRm). We aimed to characterise peripheral muscle function and body composition in pwCF on Elexacaftor/Tezacaftor/Ivacaftor (ETI) CFTRm, compared to healthy controls.
View Article and Find Full Text PDFAnn Acad Med Singap
February 2025
Graduate Institute of Medicine, Yuan Ze University, Taoyuan, Taiwan.
Introduction: The diagnosis of sarcopenia relies on key indicators such as handgrip strength, walking speed and muscle mass. Developing a composite index that integrates these measures could enhance clinical evaluation in older adults. This study aimed to standardise and combine these metrics to establish a z score for the sarcopenia composite index (ZoSCI) tailored for the ageing population.
View Article and Find Full Text PDFAuton Neurosci
February 2025
Program for Pregnancy and Postpartum Health, Neurovascular Health Laboratory, Women and Children's Health Research Institute, Alberta Diabetes Institute, Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Alberta, Canada. Electronic address:
This systematic review and meta-analysis was conducted to identify a 'normative' sympathetic response to isometric handgrip and post-exercise circulatory occlusion. Structured searches of databases were performed until June 2024. We included all primary studies (other than systematic reviews and meta-analyses), and inclusion criteria were: population (all populations); intervention (isometric handgrip and post-exercise circulatory occlusion); comparator (baseline); and outcome (MSNA).
View Article and Find Full Text PDFBMC Geriatr
March 2025
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Background: Polypharmacy (concomitant prescription of ≥ 5 medications) affects a third of older people, and evidence suggests an association with sarcopenia (loss of skeletal muscle mass/quality, muscle strength, and/or physical performance). As such, deprescribing has been recommended in routine management of sarcopenia, however it's unknown whether deprescribing is beneficial. This systematic review aimed to understand effects of deprescribing on sarcopenia parameters in older adults.
View Article and Find Full Text PDFClin Nutr ESPEN
March 2025
Department of Physiotherapy, Meander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands; Department of Dietetics and Nutrition, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.
Background & Aims: Medical nutrition therapy (MNT) is commonly used in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing intensive remission-induction treatment to prevent malnutrition, particularly the loss of fat-free mass (FFM)/muscle mass, as well as associated adverse outcomes. However, studies examining the associations between proactive versus wait-and-see approaches toward MNT and nutritional, physical, and clinical outcomes in these patients are lacking. Therefore, this study aimed to explore the associations between these different MNT approaches and body composition changes, as well as physical and clinical outcomes in AML/MDS patients undergoing intensive remission-induction treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!